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A B S T R A C T
Background: Humans acquire malaria from the bite of infected anopheline mosquitoes. Malaria is very
rarely acquired by needle sharing among intravenous drug users (IVDUs). The aim of this report is to
describe the role of injecting drug usage in malaria outbreaks occurring in malaria-free regions.
Materials andmethods: This investigationwas conducted to control a febrile illness occurring in IVDUs in
a camp near Ahvaz, a city in the southwest of Iran, during the summer of 2000. All 98 men (mean age 25
years) in this camp took part in the study. A questionnaire was completed for data collection. Peripheral
blood smears were examined for Plasmodium by Wright and Giemsa staining. Those who were positive
for Plasmodium were treated with chloroquine 600 mg immediately on day 1, with a 300 mg follow-up
dose 6 h later; this was followed by 300 mg doses on days 2 and 3.
Results: Twenty-seven patients (27.6%) were positive for Plasmodium falciparum, and all of them had
shared needles and syringes in the days before their illness. One of themen had been transferred into the
camp from Bandar Abbas two weeks previously . There were no anopheline mosquitoes in the camp
environment and none within a 1-km radius. There had been no report of malaria transmission
previously in this camp, nor among the population living within the 1-km radius. All of the cases (100%)
were negative for P. falciparum at follow-up examination.
Conclusions: With regard to increasing injecting drug addiction and the presence of malaria in some
parts of Iran, malaria should be included in the differential diagnosis of IVDU cases with fever.
 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Malaria is a febrile illness caused by a parasite named
Plasmodium.1 Reporting of malaria cases to the World Health
Organization (WHO) is improving, but is still variable. Malaria
cases still occur in the countries of the Eastern Mediterranean
Region, such as Afghanistan, Pakistan, and Iran.2 Almost all regions
of Iran are free of the disease, with the exception of the
southeastern tropical provinces of Kerman, Hormozgan, and
Sistan-Baluchestan. In the southeast, Iran borders Afghanistan
and Pakistan. The cross-border trafﬁc in this area is a prime factor
in the persistence of the disease. In addition, Iran has provided a
shelter for millions of Afghan refugees in the past years.3–5
Humans acquire malaria from the bite of infected anopheline
mosquitoes. Malaria is very rarely acquired by needle sharing
among intravenous drug users (IVDUs).6 There are only very few
reports of malaria outbreaks caused by needle sharing world-
wide.7–11 In recent years, cases of induced malaria have been* Corresponding author. Tel.: +98 611 3387724.
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doi:10.1016/j.ijid.2009.04.020reported from Brazil.8–10 Lo et al. reported that their patients
declared that they had not been to any possible transmission area
of malaria; however, all of them had taken cocaine, sharing the
same contaminated needle and syringe.10 Gonzalez Garcia et al.
reported the ﬁrst outbreak of induced malaria among heroin users
in Spain.11 The aim of this report is to describe malaria in Iran,
highlighting the role of IVDUs in malaria outbreaks occurring in
malaria-free regions.
2. Materials and methods
This investigation was conducted to control a febrile illness
occurring among IVDUs in a camp near Ahvaz, the capital city of
Khuzestan (southwest of Iran) during the summer of 2000. The
camp was a separate section of Ahvaz Prison, in which addicted
prisoners were detained to quit their addiction. The camp included
two separate sections, the ﬁrst section contained 40 people, among
whom 30 were IVDUs, and the other section contained 58 people,
of whom 42 were IVDUs. The persons in each section had no
contact with the persons in the other section, except for during
eating and sporting activities.ses. Published by Elsevier Ltd. All rights reserved.
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years) in the camp took part in this study; no new casewas allowed to
enter the camp during the investigation. A questionnaire was
completed for each case to collect the following data: age, days
spent in the camp, travel history, medication, drug addiction, route of
drug use, needle sharing, blood transfusion history, and history of
malaria. Clinical samples including blood, urine, sputum, and body
secretions and tissues were tested by Gram stain, culture, serology,
and histopathology. Peripheral blood smears were examined for the
presence of Plasmodium by Wright and Giemsa staining.12 The thick
blood smear techniquewas used for diagnosis, in accordancewith the
standards of the Iranian Ministry of Health.5,12 All the slides were
examinedwithin 24 h of blood sample collection. The diagnoses were
made at the Malaria Reference Laboratory of the Ahvaz Health Center
(AHC). A vector control investigation was performed by experts of the
AHC, and additional vector information was collected from the AHC.
Those whowere positive for Plasmodium in their blood samples were
treated with chloroquine 600 mg immediately on day 1, with a
300 mg follow-up dose 6 h later; this was followed by 300 mg doses
on days 2 and 3.5,11 Follow-up investigations, including physical
examination and peripheral blood testing for Plasmodium were
performed at 1, 2, 4, and 8 weeks after treatment.11
3. Results
Of the total 98 people, 27 (27.5%) were positive for Plasmodium
falciparum in their blood. No another pathogen (e.g., bacteria,
viruses, parasites) was detected. All of the patients declared that
they had shared needles and syringes in the days before the onset
of their illness. One of them had been transferred into the camp
two weeks previously from a prison in Bandar Abbas, the capital
city of Hormozgan Province. Therewere no anophelinemosquitoes
in the camp environment and none within a 1-km radius of the
camp.
All the persons who contracted malaria were in one section,
and all had shared injection equipment with the case who had
been transferred-in or with each other. Blood examinations for
Plasmodium detection in the other 45 IVDUs were negative (in
spite of equipment sharing in the other section); three of the
Plasmodium-negative IVDUs had shared injection equipment
with the transferred-in case or with other malaria patients.
There had been no report of malaria transmission previously in
this camp, nor among the population living within the 1-km
radius.
Data for those with and without malaria are shown in Table 1.
All of the cases (except the index case) had no history of previous
malaria or travel to a malaria endemic area. The majority of IVDUs
declared that they had illegally continued their injection drug use
in the camp. All of the cases (100%) were negative for P. falciparum
in their blood samples at follow-ups 1, 2, 4, and 8 weeks after
treatment, and there were no new cases of malaria in the camp up
to two months later.Table 1
Demographic characteristics and addiction-related variables in the studied
population.
Variable Persons with malaria Persons without malaria
Age 26.4  18.9 24.7  17.8
IVDU 27 (100) 45 (63.4)
SWIC 27 (100) 3 (4.2)
MTSC (days) 382  181 401  260
Total 27 71
IVDU, intravenous drug user; SWIC, sharing injection equipment with index case or
with malaria patient; MTSC, mean time spent in camp.
Results are mean  standard deviation or n (%).4. Discussion
The epidemiological ﬁndings of this investigation indicate
that the transmission route was not by means of the bite of
locally infected Anopheles spp mosquitoes. As the individuals
concerned did not have any history of traveling to endemic areas
or other possible exposures relating to the transmission of
malaria, the presence of a febrile illness in the IVDU cases who
were positive for P. falciparum in a camp holding drug addicts,
established a focus for the transmission. Other causes of fever
were not found. However, one of the febrile cases (the index
case) declared that he had acquired a similar illness three
months ago when he was in prison in Bandar Abbas, and that
he had not completed the ordered treatment. Ahvaz is a city that
is free of malaria transmission, but Bandar Abbas is a city in
which transmission of malaria frequently occurs.3,4,11 This
suggests that the index case caught his illness in Bandar Abbas,
and that a low parasitemia of P. falciparum due to inappropriate
treatment may have persisted in this individual for some
weeks.6,10 This could explain the origin of the cases of malaria
falciparum among the other prisoners who shared needles and
syringes with him.
We found only ﬁve reports of malaria outbreaks in drug addicts
in the literature,6–10 three from Brazil 7–9 and one from Spain.10
Our ﬁndings are in agreement with these reports. We believe this
to be the ﬁrst report and virtually the only outbreak of induced
malaria in the Eastern Mediterranean Region.
5. Conclusions
Although malaria is only rarely acquired by needle sharing
among injecting drug users, with the increasing population of
injecting drug users and the frequent occurrence of malaria in
some parts of Iran, malaria should be included in the differential
diagnosis of IVDU cases with fever in the region.
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